| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.063 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |